- Home
- ELVN vs HPP Comparison
ELVN vs HPP Comparison
Compare ELVN & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- HPP
- Stock Information
- Founded
- ELVN 2016
- HPP 1997
- Country
- ELVN United States
- HPP United States
- Employees
- ELVN N/A
- HPP N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- HPP Real Estate
- Sector
- ELVN Health Care
- HPP Finance
- Exchange
- ELVN Nasdaq
- HPP Nasdaq
- Market Cap
- ELVN 1.2B
- HPP 1.0B
- IPO Year
- ELVN 2020
- HPP 2010
- Fundamental
- Price
- ELVN $20.90
- HPP $2.70
- Analyst Decision
- ELVN Strong Buy
- HPP Hold
- Analyst Count
- ELVN 5
- HPP 10
- Target Price
- ELVN $41.20
- HPP $3.10
- AVG Volume (30 Days)
- ELVN 563.5K
- HPP 4.5M
- Earning Date
- ELVN 11-12-2025
- HPP 11-05-2025
- Dividend Yield
- ELVN N/A
- HPP N/A
- EPS Growth
- ELVN N/A
- HPP N/A
- EPS
- ELVN N/A
- HPP N/A
- Revenue
- ELVN N/A
- HPP $792,977,000.00
- Revenue This Year
- ELVN N/A
- HPP N/A
- Revenue Next Year
- ELVN $20.05
- HPP $6.49
- P/E Ratio
- ELVN N/A
- HPP N/A
- Revenue Growth
- ELVN N/A
- HPP N/A
- 52 Week Low
- ELVN $13.30
- HPP $1.78
- 52 Week High
- ELVN $30.03
- HPP $5.02
- Technical
- Relative Strength Index (RSI)
- ELVN 51.84
- HPP 46.07
- Support Level
- ELVN $19.02
- HPP $2.68
- Resistance Level
- ELVN $20.66
- HPP $2.81
- Average True Range (ATR)
- ELVN 1.00
- HPP 0.10
- MACD
- ELVN 0.09
- HPP -0.01
- Stochastic Oscillator
- ELVN 69.85
- HPP 42.11
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About HPP Hudson Pacific Properties Inc.
Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.